These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24374509)

  • 1. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.
    Merkow RP; Bilimoria KY; Tomlinson JS; Paruch JL; Fleming JB; Talamonti MS; Ko CY; Bentrem DJ
    Ann Surg; 2014 Aug; 260(2):372-7. PubMed ID: 24374509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer.
    Merkow RP; Bentrem DJ; Mulcahy MF; Chung JW; Abbott DE; Kmiecik TE; Stewart AK; Winchester DP; Ko CY; Bilimoria KY
    Ann Surg; 2013 Dec; 258(6):847-53. PubMed ID: 24169157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.
    Bassi C; Stocken DD; Olah A; Friess H; Buckels J; Hickey H; Dervenis C; Dunn JA; Deakin M; Carter R; Ghaneh P; Neoptolemos JP; Buchler MW;
    Dig Surg; 2005; 22(5):353-63. PubMed ID: 16293966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.
    Kagedan DJ; Abraham L; Goyert N; Li Q; Paszat LF; Kiss A; Earle CC; Mittmann N; Coburn NG
    Cancer; 2016 Oct; 122(20):3175-3182. PubMed ID: 27391466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative.
    Dann GC; Squires MH; Postlewait LM; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Levine EA; Jin LX; Cho CS; Winslow ER; Russell MC; Cardona K; Staley CA; Maithel SK
    J Surg Oncol; 2015 Aug; 112(2):195-202. PubMed ID: 26240027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer: a two-center retrospective cohort study.
    Åkerberg D; Björnsson B; Ansari D
    Scand J Gastroenterol; 2017 Jan; 52(1):56-60. PubMed ID: 27598522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
    Nussbaum DP; Adam MA; Youngwirth LM; Ganapathi AM; Roman SA; Tyler DS; Sosa JA; Blazer DG
    Ann Surg Oncol; 2016 Mar; 23(3):1026-33. PubMed ID: 26542590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection.
    Ellis RJ; Ho JW; Schlick CJR; Merkow RP; Bentrem DJ; Bilimoria KY; Yang AD
    Ann Surg Oncol; 2020 Mar; 27(3):909-918. PubMed ID: 31691112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.
    Sanford NN; Aguilera TA; Folkert MR; Ahn C; Mahal BA; Zeh H; Beg MS; Mansour J; Sher DJ
    J Natl Compr Canc Netw; 2019 Nov; 17(11):1292-1300. PubMed ID: 31693987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
    Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
    J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Schouwenburg MG; Busweiler LAD; Beck N; Henneman D; Amodio S; van Berge Henegouwen MI; Cats A; van Hillegersberg R; van Sandick JW; Wijnhoven BPL; Wouters MWJ; Nieuwenhuijzen GAP;
    Eur J Surg Oncol; 2018 Apr; 44(4):532-538. PubMed ID: 29439836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National assessment of margin status as a quality indicator after pancreatic cancer surgery.
    Merkow RP; Bilimoria KY; Bentrem DJ; Pitt HA; Winchester DP; Posner MC; Ko CY; Pawlik TM
    Ann Surg Oncol; 2014 Apr; 21(4):1067-74. PubMed ID: 24337612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined-modality treatment for operable pancreatic adenocarcinoma.
    Pisters PW; Wolff RA; Crane CH; Evans DB
    Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
    Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
    Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.